Semin Neurol 2002; 22(1): 009-016
DOI: 10.1055/s-2002-33044
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

What I Have Learned About Infectious Diseases with My Sleeves Rolled Up

Karen L. Roos
  • John and Nancy Nelson Professor of Neurology, Indiana University, Indianapolis, Indiana
Further Information

Publication History

Publication Date:
12 August 2002 (online)

ABSTRACT

The questions most often asked of my residents and myself are the following: (1) How do you interpret the cerebrospinal fluid white blood cell count and polymerase chain reaction results when the lumbar puncture has been traumatic? (2) Does the older adult with a serum sample that tests positive by the Venereal Disease Research Laboratory test need spinal fluid analysis for neurosyphilis, and which of those syphilis tests can become nonreactive even though the patient is never treated? (3) Do you give steroids to patients with bacterial meningitis? (4) What do you do for the patient with cryptococcal meningitis who develops a spastic gait? (5) Are all cases of transverse myelitis ``idiopathic''? and (6) When does the patient who has had a stroke need spinal fluid analysis to rule out an infectious etiology? This is how we answer these questions.

REFERENCES

  • 1 Bonadio W A. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis.  Pediatr Infect Dis J . 1992;  11 423-432
  • 2 Dougherty J M, Roth R M. Cerebral spinal fluid.  Emer Med Clin North Amer . 1986;  4 281-297
  • 3 Conley J M, Ronald A R. Cerebrospinal fluid as a diagnostic body fluid.  Amer J Med . 1983;  75 102-106
  • 4 Fishman R A. Composition of the cerebrospinal fluid. In: Fishman RA, ed. Cerebrospinal Fluid in Diseases of the Nervous System Philadelphia: W.B. Saunders 1992: 183-252
  • 5 Corbett J J, Mehta M P. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri.  Neurology . 1983;  33 1386-1388
  • 6 Aksamit A J. Cerebrospinal fluid in the diagnosis of central nervous system infections. In: Roos KL, ed. Central Nervous System Infectious Diseases and Therapy New York: Marcel Dekker 1997: 731-745
  • 7 Lakeman F D, Whitley R J, and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease.  J Infect Dis . 1995;  171 857-863
  • 8 Burkhard P R, Sanchez J C, Landis T, Hochstrasser D F. CSF detection of the 14-3-3 protein in unselected patients with dementia.  Neurology . 2001;  56 1528-1533
  • 9 Neal J B, Jackson H W, Appelbaum E. Epidemic meningitis.  JAMA . 1926;  87 1992-1995
  • 10 Swartz M D, Dodge P R. Bacterial meningitis: a review of selected aspects.  N Engl J Med . 1965;  272 725-1010
  • 11 Carpenter R R, Petersdorf R G. The clinical spectrum of bacterial meningitis.  Am J Med . 1962;  33 262-275
  • 12 Thorner A R, Walker D H, Petri W A. Rocky Mountain spotted fever.  Clin Infect Dis . 1998;  27 1353-1359
  • 13 Helmick C G, Bernard K W, D'Angelo L J. Rocky Mountain spotted fever: clinical, laboratory and epidemiological features of 262 cases.  J Infect Dis . 1984;  150 480-488
  • 14 Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat.  CID . 2001;  32 897-928
  • 15 Augenbraun M H, Rolfs R. Treatment of syphilis, 1998; nonpregnant adults.  Clin Infect Dis . 1999;  S21-28
  • 16 Hook E W, Marra C M. Acquired syphilis in adults.  N Engl J Med . 1992;  326 1060-1069
  • 17 Centers for Disease Control and Prevention. 1998 sexually transmitted diseases treatment guidelines.  MMWR . 1998;  47(RR-11) 1-116
  • 18 Gottfredsson M, Perfect J R. Fungal meningitis.  Semin Neurol . 2000;  20 307-322
  • 19 Valtonen V V. Infection as a risk factor for infarction and atherosclerosis.  Ann Med . 1991;  23 539-543
  • 20 Matthay M A. Severe sepsis: a new treatment with both anticoagulant and anti-inflammatory properties.  N Engl J Med . 2001;  344 759-762
  • 21 Lorente J A, Garcia-Frade L J, Landin L. Time course of hemostatic abnormalities in sepsis and its relation to outcome.  Chest . 1993;  103 1536-1542
  • 22 Petty G W, Duffy J, Huston J. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia.  Mayo Clin Proc . 1996;  71 671-678
  • 23 Fryer R H, Schwobe E P, Woods M L, Rodgers G M. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity.  J Investig Med . 1997;  45 168-174
  • 24 Dechend R, Maass M, Gieffers J, Dietz R. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis.  Circulation . 1999;  100 1369-1373
  • 25 Parker P, Puck J, Fernandez F. Cerebral infarction associated with Mycoplasma pneumoniae Pediatrics .  1981;  67 373-375